Fibrous Proteins in Medical Technology: related news

Fibrous Proteins in Medical Technology

As many sectors of medical technology move away from traditional metals and plastics towards more sophisticated materials derived from supramolecular chemistry, some of the principles developed by nature’s best engineering materials are being borrowed. Discussed here are the structural characteristics of fibrous proteins.

TechConnect World 2009 Matches Tomorrow's Technology Solutions with Today's Business Needs for Clean-Technology, Biotechnology and Nanotechnology

The Largest Technology Matchmaking Event in the US Comes to Houston, May 3-7, 2009 at the George R. Brown Convention Center HOUSTON, Oct. 27 /PRNewswire/ -- The Nano Science and Technology Institute (NSTI), and the Clean Technology and Sustainable Industries Organization (CTSI), today announced that the 2009 TechConnect World Conference and Expo will take place May 3-7, 2009 at the George R. Brown Convention Center in Houston, Texas. TechConnect World is an information and networking exchange where executives from Fortune 500 companies present technological challenges in the areas of Clean-technology (such as traditional energy, renewable energy, and sustainability), Nanotechnology, and Biotechnology - to the academic and research communities - who in turn, discuss how their current research projects might be applied or adapted to address

Houston Technology Center Hosts Inaugural Gulf Coast Innovation Conference

HOUSTON--(BUSINESS WIRE)--The Houston Technology Center (HTC), a business accelerator that assists Houston-based emerging technology companies, is hosting its Gulf Coast Innovation Conference, which will feature presentations from emerging technology companies in the energy, life sciences, nanotechnology, information technology and aerospace technology industries. The conference will be held on Tuesday, November 18, at the InterContinental Hotel Houston.

Panasonic and Renesas Technology to Collaborate on Development of SoCs at 32-nm Process Node

Panasonic Corporation and Renesas Technology Corp. are now collaborating on the development of elemental process technologies for SoCs of the 32-nm node. The two companies are confident that their 32-nm node transistor technology and other advances can soon be applied to products in mass production. The 32-nm SoC process employs a developed transistor technology with a metal/high-k1 gate stack structure and interconnect technology, using a low-k2 material. To achieve a device using complementary metal-insulator semiconductor (CMIS)3 technology, a type of complementary Metal Oxide Semiconductor (CMOS), at a 32-nm node, an ultrathin film cap layer4 is applied at the atomic level to transistors with a metal/high-k gate stack structure under optimized conditions.

ReachMD(TM) Launches First Ever Continuing Medical Education (CME) iPhone Application for Doctors

CHICAGO, Oct. 23 /PRNewswire/ -- ReachMD XM satellite radio channel 157 has launched the first ever-continuing medical education (CME) application for the Apple iPhone and iTouch. This application will allow users to listen to fully accredited CME programs, get exclusive updates on new CME content each week, and take CME tests for credit with one click on their iPhone or iTouch. In announcing this new application, Gary Epstein, CEO of ReachMD, said, "Busy physicians are seeking convenient and high quality medical education to stay current and to fulfill requirements. It is our mission to deliver the best medical information and education available today in a multi-channel platform. This new iPhone application adds to all of our other innovative ways to reach medical professionals and provides access to the latest medical news and informat

Nomir Medical wins European patent on Noveon technology

Nomir Medical Technologies, a medical device company, has announced that the European Patent Office has granted a patent to the company which protects its core Noveon technology.

Nomir Medical Wins European Patent on Noveon Technology

Nomir Medical Technologies, a medical device company, has announced that the European Patent Office has granted a patent to the company which protects its core Noveon technology.

Nomir Medical Technologies Granted European Patent on Core Noveon(R) Technology

Nomir Medical Technologies, a leader in the development of optical energy technologies for medical applications, announced today that The European Patent Office has granted a patent to Nomir which protects its core Noveon(R) technology. The Noveon is a light-based system that targets the elimination of bacterial and fungal infections through a unique near-infrared photo-inactivation effect, while preserving healthy tissue and promoting recovery.

Corgenix Medical Receives U.S. Patent On technology to identify atherosclerotic cardiovascular disease

(RTTNews) - Thursday, Corgenix Medical Corp. (CONX.OB: News ) said it received a third U.S. patent for the technology incorporated in its AtherOx product group, a next-generation technology to identify individuals at risk for developing atherosclerotic cardiovascular disease.

Nomir Medical Technologies Granted European Patent On Core Noveon Technology

WALTHAM, Mass.--(BUSINESS WIRE)--Nomir Medical Technologies, a leader in the development of optical energy technologies for medical applications, announced today that The European Patent Office has granted a patent to Nomir which protects its core Noveon® technology. The Noveon is a light-based system that targets the elimination of bacterial and fungal infections through a unique near-infrared photo-inactivation effect, while preserving healthy tissue and promoting recovery.

Power3 Medical files two patent applications for breast cancer blood test

Add our medical news to StumbleUpon - Power3 Medical files two patent applications for breast cancer blood test Add our medical news to Facebook - Power3 Medical files two patent applications for breast cancer blood test

Corgenix receives third U.S. patent on AtherOx technology

Add our medical news to StumbleUpon - Corgenix receives third U.S. patent on AtherOx technology Add our medical news to Facebook - Corgenix receives third U.S. patent on AtherOx technology

Ocimum Biosolutions awarded two U.S. patents for gene expression technology

Add our medical news to StumbleUpon - Ocimum Biosolutions awarded two U.S. patents for gene expression technology Add our medical news to Facebook - Ocimum Biosolutions awarded two U.S. patents for gene expression technology

Scientists develop genome-wide platform to study how specialized proteins regulate RNA in living, intact cells

Add our medical news to StumbleUpon - Scientists develop genome-wide platform to study how specialized proteins regulate RNA in living, intact cells Add our medical news to Facebook - Scientists develop genome-wide platform to study how specialized proteins regulate RNA in living, intact cells

Researching Medical Literature on the Internet - 2008

The Internet is an accepted place to turn for research, and nowhere has this become more apparent than in the fields of medicine and health care. A veritable explosion of available medical information seeks to meet the needs of both professionals and the public. In fact, many professionally-oriented health care sites have evolved to meet consumer needs, and consumer-oriented sites often include professional literature. Although sites for consumers and support groups make up an important and extremely useful segment of health care web sites, I will concentrate on the needs of the professional researcher. For example, legal researchers, who often have to consult medical sources, usually do not have a medical library at hand. We can appreciate that the Internet provides free access to a great deal of the medical literature, either in full te

T2 Biosystems Announces Strategic Investment and Technology Development Agreement with In-Q-Tel

T2 Biosystems, Inc., a company developing the first portable medical diagnostic products which combine nanotechnology and miniaturized magnetic resonance (MR) technology, today announced a strategic investment and technology advancement agreement with In-Q-Tel, the independent strategic investment firm that identifies innovative technology solutions to support the mission of the broader U.S. Intelligence Community. The In-Q-Tel investment is also part of a $10.8 million Series B funding round, with additional participation by Flagship Ventures, Polaris Venture Partners, Flybridge Capital Partners and Partners Healthcare. This agreement will fund the further development and enhancement of T2 Biosystems' revolutionary diagnostic systems, as well as identify opportunities within the intelligence community for field applications.

T2 Biosystems Announces Strategic Investment and Technology Development Agreement with In-Q-Tel

CAMBRIDGE, Mass. - (Business Wire) T2 Biosystems, Inc., a company developing the first portable medical diagnostic products which combine nanotechnology and miniaturized magnetic resonance (MR) technology, today announced a strategic investment and technology advancement agreement with In-Q-Tel, the independent strategic investment firm that identifies innovative technology solutions to support the mission of the broader U.S. Intelligence Community. The In-Q-Tel investment is also part of a $10.8 million Series B funding round, with additional participation by Flagship Ventures, Polaris Venture Partners, Flybridge Capital Partners and Partners Healthcare. This agreement will fund the further development and enhancement of T2 Biosystems

T2 Biosystems Announces Strategic Investment and Technology Development Agreement with In-Q-Tel

CAMBRIDGE, Mass. (Business Wire) -- T2 Biosystems, Inc., a company developing the first portable medical diagnostic products which combine nanotechnology and miniaturized magnetic resonance (MR) technology, today announced a strategic investment and technology advancement agreement with In-Q-Tel, the independent strategic investment firm that identifies innovative technology solutions to support the mission of the broader U.S. Intelligence Community. The In-Q-Tel investment is also part of a $10.8 million Series B funding round, with additional participation by Flagship Ventures, Polaris Venture Partners, Flybridge Capital Partners and Partners Healthcare. This agreement will fund the further development and enhancement of T2 Biosystems' revolutionary diagnostic systems, as well as identify opportunities within the intelligence community

NASA Specifies Hypertac(R) "Basket of Wires" Technology for all Space Flight Applications

HUDSON, Mass. --(Business Wire)-- Smiths Interconnect, a division of the global technology business Smiths Group today announces that Hypertronics cPCI connectors, featuring the trademarked Hypertac "Basket of Wires" technology are the only approved Compact PCI connectors for NASA space flight applications. Further, extensive testing of the Hypertac "Basket of Wires" technology has now resulted in NASA issuing an addendum to EEE-INST-002 prohibiting the use of both tuning fork and press fit connectors and formally recommending the Hypertac connector technology for use on all future space flight hardware.

Researchers make thought processes visible with fluorescent proteins in the brain

(Nanowerk News) Thought processes made visible: An international team of scientists headed by Mazahir Hasan of the Max Planck Institute for Medical Research in Heidelberg has succeeded in optically detecting individual action potentials in the brains of living animals. The scientists introduced fluorescent indicator proteins into the brain cells of mice via viral gene vectors: the illumination of the fluorescent proteins indicates both when and which neurons are communicating with each other. This new method enables the observation of brain activity over a period of many months and provides new ways of identifying, for example, the early onset of dysfunction in neurological disorders such as Alzheimer’s and Parkinson’s. The fluorescent proteins could also provide scientists with information about the ways in which normal aging processes a

Geoexchange Technology Manufacturer Essential Innovations Announces Revolutionary Patent-Pending "Communication & Controls" Technology

Geoexchange Technology Manufacturer Essential Innovations Announces Revolutionary Patent-Pending "Communication & Controls" Technology

Geoexchange Technology Manufacturer Essential Innovations Announces Revolutionary Patent-Pending "Communication & Controls" Technology

Geoexchange Technology Manufacturer Essential Innovations Announces Revolutionary Patent-Pending "Communication & Controls" Technology

Geoexchange Technology Manufacturer Essential Innovations Announces Revolutionary Patent-Pending "Communication & Controls" Technology

Geoexchange Technology Manufacturer Essential Innovations Announces Revolutionary Patent-Pending "Communication & Controls" Technology

Corgenix Medical Corporation receives approval for third US Patent on AtherOx Technology

Corgenix Medical Corporation (OTC BB: CONX), a developer and marketer of diagnostic test kits, declared on 25 September the receipt of its third US patent (PATENT # 7,422,864) from the US Patent Office for AtherOx Technology, to identify individuals at risk for developing atherosclerotic cardiovascular disease.

Aspen Technology to Present at the UBS Global Technology & Services Conference

BURLINGTON, Mass. (Business Wire) -- Aspen Technology, Inc. (OTC: AZPN.PK), a leading provider of software and services to the process industries, today announced its President and Chief Executive Officer, Mark Fusco, will present at the UBS Global Technology & Services Conference, being held at the Grand Hyatt Hotel in New York City.

Search took 0.35 seconds.